CROs/Service Providers

Proteus and Otsuka to develop novel digital health products

Friday, July 6, 2012 11:24 AM

Proteus Digital Health, developer of wearable and ingestible sensor technology, and Otsuka Pharmaceutical, a global healthcare company based in Japan, have entered into an exclusive worldwide license and collaboration agreement to develop and commercialize a new category of medicines.

More... »

Genstar Capital completes ERT acquisition

Thursday, July 5, 2012 09:12 AM

Genstar Capital, a private equity firm, has completed its acquisition of ERT, a global technology-driven provider of health outcomes, in a take-private transaction valued at approximately $400 million.

More... »

Natus completes acquisition of Nicolet neurodiagnostic business

Tuesday, July 3, 2012 10:32 AM

Natus Medical, a San Carlos, Calif.-based provider of healthcare products, has completed the acquisition of the Nicolet neurodiagnostic business from CareFusion for an approximate $58 million cash.

More... »

Sorin Group acquires CalMed for $14M

Tuesday, July 3, 2012 10:14 AM

Sorin Group, a global medical device company with a focus on cardiovascular diseases, has acquired California Medical Laboratories (CalMed), a manufacturer of high quality cardiovascular cannulae, for $14 million.

More... »

Catalyst stockholders approve SXC merger

Tuesday, July 3, 2012 09:55 AM

Stockholders attending a special meeting for Catalyst Health Solutions, a fast-growing national pharmacy benefit management (PBM) company, have approved, among other things, the proposal to adopt the previously disclosed agreement and plan of merger with SXC Health Solutions, a Lisle, Ill.-based provider of PBM services and healthcare information technology solutions.

More... »

PharMerica introduces $25M share purchase program

Tuesday, July 3, 2012 09:22 AM

The board of directors of PharMerica, a national provider of institutional pharmacy and hospital pharmacy management services, has authorized an increase in its existing share purchase program that will allow the company to purchase up to $25 million of its common stock in the open market through unsolicited or solicited privately negotiated transactions, or in such other appropriate manner, and will be funded from available cash.

More... »

Pernix Therapeutics to acquire Great Southern Laboratories

Tuesday, July 3, 2012 09:08 AM

Pernix Therapeutics Holdings, a specialty pharmaceutical company of The Woodlands, Texas, has entered into a definitive agreement to acquire Great Southern Laboratories, a privately-held pharmaceutical contract manufacturing company of Houston, Texas.

More... »

Theradiag acquires Prestizia and microRNA technology platform

Monday, July 2, 2012 11:31 AM

Theradiag, a French theranostics and in vitro diagnostics company focused on autoimmune disease, has decided to acquire Prestizia, a French biotechnology company that develops microRNA technology.

More... »

ScinoPharm invests $37M in high potency cytotoxic injectable plant

Friday, June 29, 2012 02:50 PM

ScinoPharm, a Taiwanese provider of oncological APIs for injectable products, has decided to invest $37.6 million in the construction of a high potency cytotoxic injectable plant suitable for production of oncological injectable products on the company's premise at the Tainan Science Park.

More... »

Fluxion Biosciences, Stanford collaborate on circulating tumor cell analysis

Friday, June 29, 2012 11:45 AM

Fluxion Biosciences, a San Francisco-based provider of cellular analysis tools for use in critical life science, has formed a collaboration with the Stanford University School of Medicine to develop tests to help deliver more effective therapies to cancer patients.

More... »